Steve Woodruff is hopping mad with the apparent gross inefficiency and indecision of the “guidance process” for pharma company promotional practices when it comes to social media, and I can’t blame him!
But I’m on the FDA’s side this time.
Let me say up front that I never liked how the FDA remains vague and slow in the past, it sucked when I was a pharma employee trying to figure out just what the FDA “wants”, but the FDA had long acted like a tripped out lover who has something in mind but we’re supposed to guess or better yet – read his mind.
But today I am much more forgiving of the FDA than I am of pharma company management.
I was looking at a recent run down of 2010â€²s lawsuits settled by drug companies and to say that Iâ€™m disappointed with industryâ€™s continual hypocrisy is a gross understatement.
Itâ€™s one thing when you can say that youâ€™re working toward implementation of compliance practices. Itâ€™s another when you take one step forward and 3 steps back as an industry in something as â€œcommon senseâ€ as â€œdonâ€™t mislead the publicâ€ (in every which way that can be done via old media/new media).
For so many years whether as employee or consultant, I have heard company management say â€œPatients are our #1 concern! People are our greatest asset! We want to do the right thing!â€ in public forums and company meetings. Then I look at the actions that are motivated by incentives and hidden rules at companies.
Iâ€™m not surprised why the government keeps ramping up its prosecution arm. I get that pharma changes are slow, but this looks almost as if pharma wants to test how slow it can change.
Iâ€™m not surprised the FDA has to â€œslow down to keep upâ€.
I have read some of the recent untitled warning letters sent to pharmacos, and the violative actions from pharmacos. HAVE YOU READ THESE? Look at the list growing from year to year. And how the SAME CITATIONS KEEP COMING UP, AGAIN AND AGAIN.
If I had to cull through the sheer amount of garbage that pharmacos continue to churn out as sales aid, my resources would come up short as well.
It’s like, pharma companies can’t learn!
It makes me want to say, “come on pharmaco people, you guys come armed with MBAs and doctorate degrees, you have teams of lawyers…. SERIOUSLY? THIS TYPE OF VIOLATION – STILL?”
Or more accurately, maybe they just don’t want to learn.
Maybe it’s still a game to see how much money you can make when you push the envelope and offset the profits with FDA imposed penalties and fines.
Even when you slapped with a huge lawsuit costing you hundreds of millions of dollars, well you can act like this is the stock market and say if you earned more revenue than lose it as a liability of “market fluctuation or market conditions” you’ll still come out on top.
Meanwhile, patients lose, healthcare loses, and pharma employees who actually want to do the right thing when earning their keep lose.